Rizatriptan Benzoate
- Product NDC
- 55700-942
- 11-digit product format
- 557000942
- Labeler code
- 55700
- Product ID
- 55700-942_e4fca006-539a-42b7-a3ee-880563129f35
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rizatriptan Benzoate
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- Quality Care Products, LLC
- Application
- ANDA203062
- Marketing category
- ANDA
- Marketing start
- 2021-09-10
- Marketing end
- 0000-00-00
- Substance
- RIZATRIPTAN BENZOATE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 55700-942 | D | Discontinued by firm | 2026-08-07 | ||
| excluded package | package | 55700-942 | 55700-942-18 | D | Discontinued by firm | 2026-08-07 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | 55700-942 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… | ||
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 55700-942 | 55700-942-18 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A203062-001 | RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | |
| A203062-002 | RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A203062-001 | AB |
| A203062-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A203062-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A203062-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203062-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203062-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A203062-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A203062-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203062-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203062-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203062-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203062-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203062-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203062-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203062-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203062-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203062-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203062-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203062-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203062-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A203062-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A203062-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203062-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203062-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203062-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203062-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203062-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203062-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A203062-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A203062-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A203062-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A203062-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A203062-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A203062-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A203062-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A203062-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A203062-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A203062-002 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A203062-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A203062-002 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A203062-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A203062-002 | AB | 1 | 782e0a99824c… |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55700-942-18 | EA - Each | 55700-942 | 2180a519-494a-4131-972d-22ae1aa42eed | 1 | 2021-10-08 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Bryant Ranch Prepack | 11a7f243-3a8b-41fd-a9fa-1dd2dcafab93 | 2026-02-04 | Warnings, Adverse reactions | 203062 ANDA203062 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Advanced Rx of Tennessee, LLC | 4137a02e-dcec-c14c-e063-6294a90aa44f | 2025-10-21 | Warnings, Adverse reactions | 203062 ANDA203062 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Golden State Medical Supply, Inc. | 07605de4-bef2-70e8-e063-6394a90a33cc | 2025-08-20 | Warnings, Adverse reactions | 203062 ANDA203062 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Aurobindo Pharma Limited | a8e37688-426c-4290-933d-54a34ae86000 | 2025-08-06 | Warnings, Adverse reactions | 203062 ANDA203062 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | REMEDYREPACK INC. | 1e547fac-a9e5-4c7b-adba-4e6b75141183 | 2025-06-19 | Warnings, Adverse reactions | 203062 ANDA203062 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Asclemed USA, Inc. | 8fa794f4-4253-485d-b4ee-986178031339 | 2025-01-27 | Warnings, Adverse reactions | 203062 ANDA203062 |
| Rizatriptan Benzoate ODT | RIZATRIPTAN BENZOATE ODT | Direct Rx | db489d19-1509-c979-e053-2a95a90a4410 | 2025-01-22 | Warnings, Adverse reactions | 203062 ANDA203062 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Bryant Ranch Prepack | 74971372-75c6-4682-adbf-1c8e7b748fc1 | 2024-10-01 | Warnings, Adverse reactions | 203062 ANDA203062 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Rising Pharma Holdings, Inc. | 2337e102-8df0-4e7f-81d8-5cb86cd48674 | 2024-02-19 | Warnings, Adverse reactions | 203062 ANDA203062 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | NuCare Pharmaceuticals,Inc. | 106dd370-c09c-556a-e063-6394a90acfed | 2024-02-02 | Warnings, Adverse reactions | 203062 ANDA203062 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Proficient Rx LP | 80c124ab-a083-4184-ba6b-199a7681b5d1 | 2023-09-01 | Warnings, Adverse reactions | 203062 ANDA203062 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 55700-942-18 | 55700094218 | 3 BLISTER PACK in 1 CARTON (55700-942-18) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK | 3 blister pack | 2021-09-10 | 0000-00-00 | No | No | Current |